Max Kates, M.D.

Max Reuben Kates, M.D.

Headshot of Max Kates
  • Division Director, Urologic Oncology
  • Associate Professor of Urology
Male

Expertise

Bladder Cancer, Prostate Cancer, Robotic Cystectomy, Robotic Prostatectomy, Robotic Surgery, Urinary Diversion ...read more

Request an Appointment

Insurance Information

Main Phone

Outside of Maryland & Washington D.C.

Request Appointment

International Patients

Request Appointment

Locations

The Johns Hopkins Hospital

Appointment Phone: 410-955-6100
600 N. Wolfe Street
Baltimore, MD 21287
The Johns Hopkins Hospital - Google Maps

Johns Hopkins Medicine - Green Spring Station

Appointment Phone: 410-955-6100
10803 Falls Road
Pavilion III, Suite 3300
Lutherville, MD 21093
Phone: 410-616-7600 | Fax: 410-616-7601
Johns Hopkins Medicine - Green Spring Station - Google Maps

Johns Hopkins Outpatient Center (now called Levi Watkins, Jr., M.D., Outpatient Center)

Appointment Phone: 410-955-6100
601 N. Caroline St.
Urology, 4th Floor
Baltimore, MD 21287
Fax: 410-502-6454
Johns Hopkins Outpatient Center (now called Levi Watkins, Jr., M.D., Outpatient Center) - Google Maps

Background

Dr. Max Kates is an Associate Professor of Urology and Oncology in the Brady Urological Institute. He also directs the Division of Urologic Oncology for the Brady Urological Institute. 

Dr. Kates completed his undergraduate degree at Wesleyan University in Connecticut before pursuing his medical degree at Mount Sinai School of Medicine in New York. He then went on to train at Johns Hopkins for his urologic residency and Society of Urologic Oncology (SUO) fellowship. 

 Dr. Kates has expertise in all areas of urologic oncology, with a particular emphasis on bladder and prostate cancer. With training in open, endoscopic, and robotic surgical approaches, Dr. Kates’ surgical philosophy is to assess the unique needs of each patient, and develop the right treatment plan for their malignancy. He is very hands on in his approach in the clinic and the operating room, and believes open communication with the patient, the patient’s family, and referring providers is key to ensuring a speedy recovery.  

As the clinical director of the bladder cancer multidisciplinary clinic, Dr. Kates works with the team at the Johns Hopkins Greenberg Bladder Cancer Institute to deliver a personalized approach to bladder cancer utilizing cutting edge precision medicine approaches. 

Dr. Kates’ research interests involve novel treatments for cancers of the urinary tract. Dr. Kates has authored more than 135 journal articles in the fields of bladder, prostate, and kidney cancer. He currently has a provisional patent for a novel intravesical chemotherapy developed with nano-engineer collaborators. Additionally, Dr. Kates has made important discoveries into the mechanism of action of intravesical BCG, the most common treatment for bladder cancer.  He is the principal investigator on multiple trials, and is currently leading EA8212 BRIDGE, which is a randomized trial open in over 150 centers in the United States comparing BCG to GemDoce chemotherapy for early stage bladder cancer.  

To inquire about an appointment or make a referral, Dr. Kates can be contacted by phone (410) 614-0009. 

 

...read more

Titles

  • Division Director, Urologic Oncology
  • Director, Bladder Cancer Program
  • Associate Professor of Urology
  • Associate Professor of Oncology

Departments / Divisions

Centers & Institutes

Education

Degrees

  • MD; Mount Sinai School of Medicine (2012)

Residencies

  • Urology; Johns Hopkins University School of Medicine (2018)

Board Certifications

  • American Board of Urology (Urology) (2022)

Research & Publications

Selected Publications

View all on PubMed

Dr. Kates has more than 90 publications in peer-reviewed journals. Please click the following link to access Dr. Kates' published research:  https://www.ncbi.nlm.nih.gov/myncbi/1zMJZ_6g-QhwtB/bibliography/public/

Activities & Honors

Honors

  • Finalist, Truman Scholar, 2005
  • Team Captain, Wood Memorial Award, Wesleyan University Tennis Team, 2006
  • Medical Student Training in Aging Research (MSTAR) Scholar, 2009
  • Alpha Omega Alpha (AΩA) Honor Medical Society, Mount Sinai School of Medicine, 2011
  • Gold Humanism Honor Society, Mount Sinai School of Medicine, 2011
  • Oral Presentation Award, Mount Sinai Medical Student Research Day, 2011
  • Distinction in Research, Mount Sinai School of Medicine, 2012
  • Harold Lamport Biomedical Research Award, 2012
  • Johns Hopkins Walter and Lucille Rubin Research Award, 2014
  • AUA Urology Care Foundation Russell W Scott Resident Scholar, 2015
  • Johns Hopkins Septembeard Research Scholar Award, 2015
  • Bladder Cancer Advocacy Network (BCAN) John Quale Travel Fellow, 2015
  • Mid-Atlantic AUA Resident Essay Prize, 2016
  • Society of Urologic Oncology Annual Meeting 1st prize Poster Award, 2016
  • Best Reviewer Urologic Oncology: Seminars and Original Investigations, 2016
  • Best Reviewer Urologic Oncology: Seminars and Original Investigations, 2017
  • American Urological Association Annual Meeting 1st prize Poster Award, 2018

Videos & Media

Recent News Articles and Media Coverage

Podcast: What Are Biomarkers and Why Do They Matter to Bladder Cancer Patients? 

Recorded February 22, 2022 

 

Podcast: Bladder Cancer

Recorded February 2, 2022

Is this you? Edit Profile
back to top button